（来源：新华日报） □ 本报记者 黄红芳 1月6日，全国工商联、人社部、全国总工会联合举办"全国就业与社会保障先进民营企业暨关爱员工实 现双赢表彰大会"，我省江苏中天科技股份有限公司等6家企业获评"全国就业与社会保障先进民营企 业"，亨通集团工会委员会获评"全国双爱双评先进企业工会"，苏州富士莱医药股份有限公司董事长钱 祥云获评"全国关爱员工优秀民营企业家"，无锡恒业电热电器有限公司研发部部长兼技术总监赵成旺获 评"全国热爱企业优秀员工"。 荣誉背后是一个个"不裁员"的郑重承诺、一笔笔解困救急的暖心基金、一套套助力成长的培养体系。走 进这些优秀民营企业你会发现，"好工作"的定义远比想象中更具体也更温暖。 不裁员， 赢得了忠诚激发了创造力 就业是最大的民生。尤其在经济面临挑战时期，企业的每一个用工决策，牵动着无数家庭的生计。 位于南通的中天科技此次获得"全国就业与社会保障先进民营企业"称号，"不裁员"，是该企业对1.6万 多名员工的郑重承诺。公司在集团内部建立人才市场，消化富余人员，"五险一金"足额顶格缴纳，确保 员工利益不受影响。企业坚持"增产增薪，减产不减薪"，没有把近千名因政策衔接问题暂时无法享受退 休待 ...

证券日报网讯1月5日，富士莱（301258）在互动平台回答投资者提问时表示，截至2025年12月31日股东 总户数为9955户。 ...

1月5日，富士莱盘中上涨2.00%，截至11:07，报33.15元/股，成交1489.13万元，换手率0.51%，总市值 30.39亿元。 富士莱今年以来股价涨2.00%，近5个交易日跌0.45%，近20日涨2.16%，近60日跌1.37%。 机构持仓方面，截止2025年9月30日，富士莱十大流通股东中，银河康乐股票A（519673）位居第九大 流通股东，持股17.81万股，为新进股东。 资料显示，苏州富士莱医药股份有限公司位于江苏省常熟新材料产业园海旺路16号，成立日期2000年11 月27日，上市日期2022年3月29日，公司主营业务涉及原料药及中间体、保健品原料的研发、生产和销 售。主营业务收入构成为：硫辛酸系列产品66.02%，肌肽系列产品14.86%，艾瑞昔布11.88%，磷脂酰 胆碱系列产品5.95%，其他(补充)1.29%。 责任编辑：小浪快报 截至12月19日，富士莱股东户数9810.00，较上期减少0.01%；人均流通股9079股，较上期增加0.01%。 2025年1月-9月，富士莱实现营业收入3.23亿元，同比增长3.23%；归母净利润7339.66万元，同比增长 430.16%。 分红方 ...

记者12月30日从中国汽车技术研究中心有限公司（以下简称"中汽中心"）获悉，该中心规划建设的智能 网联新能源汽车全季冰雪试验基地项目日前在内蒙古呼伦贝尔正式启动。基地建成后将成为全球规模最 大、功能最全、技术最先进的全季节冬季汽车试验场。 "新发展、新技术对寒区测试提出了新的需求。"中汽中心副总经理张嘉禾表示，一是稳定的试验条件需 求，随着冬季标定试验复杂化、精细化，需要稳定的冰雪路面、可控的环境条件，提升试验的可重复 性；二是可控的智驾冰雪场景需求，智驾运行场景的扩展，必须搭建可控的冰雪测试场景，保障智驾在 寒区环境下功能安全；三是时间不受限制的试验需求，新车型研发周期由原来48个月大幅压缩至18个 月，每年3—4个月的冬季标定试验窗口期已经成为发展的瓶颈。 该基地项目由中汽中心所属中汽研汽车试验场股份有限公司投资12亿元规划建设。基地占地约1000亩， 规划建设智能网联新能源汽车三电（电池、电机、电驱）系统标定、底盘系统低附标定、降雪场景模拟 测试、底盘系统高附动态广场及飞行汽车测试等五大功能区。项目建成后，将构建"季节性室外测试 +全季节室内测试"的协同服务网络，为我国智能网联新能源汽车寒区研发的技术创 ...

苏州鲲泰生物科技有限公司，成立于2022年，位于苏州市，是一家以从事研究和试验发展为主的企业。 企业注册资本5000万人民币。通过天眼查大数据分析，苏州鲲泰生物科技有限公司参与招投标项目6 次，专利信息4条，此外企业还拥有行政许可4个。 声明：市场有风险，投资需谨慎。本文为AI基于第三方数据生成，仅供参考，不构成个人投资建议。 来源：市场资讯 国家知识产权局信息显示，苏州富士莱医药股份有限公司；苏州鲲泰生物科技有限公司取得一项名 为"一种L96侧链化合物的制备方法"的专利，授权公告号CN118993970B，申请日期为2023年5月。 天眼查资料显示，苏州富士莱医药股份有限公司，成立于2000年，位于苏州市，是一家以从事化学原料 和化学制品制造业为主的企业。企业注册资本9167万人民币。通过天眼查大数据分析，苏州富士莱医药 股份有限公司共对外投资了4家企业，参与招投标项目57次，财产线索方面有商标信息20条，专利信息 108条，此外企业还拥有行政许可82个。 ...

证券日报网讯12月22日，富士莱（301258）在互动平台回答投资者提问时表示，截至2025年12月19日股 东总户数为9810户。 ...

证券日报网讯12月11日，富士莱（301258）在互动平台回答投资者提问时表示，截至2025年12月10日股 东总户数为9811户。 ...

Group 1 - The new national standard for electric bicycles has been implemented since December, enforcing a speed limit of 25 km/h that cannot be unlocked [1] - Manufacturers face strict penalties for violating the new regulations, leading to the complete closure of speed unlocking channels [1] - Multiple electric bicycle brands confirm that the speed limit is secured by a triple anti-tampering mechanism, making it impossible to unlock [1] Group 2 - The new standard includes built-in Beidou positioning systems in electric bicycles to monitor speed, replacing previous brand-specific navigation systems [1] - Industry insiders indicate that consumers needing higher speeds must switch to electric motorcycles, which require a license and registration [1] - Due to price increases in electric bicycles, some users may consider directly purchasing electric motorcycles instead [1]

证券日报网讯 12月9日晚间，富士莱发布公告称，公司于近日收到国家药品监督管理局签发的关于硫辛 酸片的《药品注册证书》。 （文章来源：证券日报） ...

Group 1 - Wanma Technology has been pre-awarded a total of 59.9434 million yuan for multiple State Grid projects, which accounts for 14.49% of its latest audited main business revenue [1] - Tianen Kang's subsidiary received a drug registration certificate for Methimazole tablets, a medication used for hyperthyroidism [2] - Taijing Technology invested 10 million yuan to establish a special fund focused on high-speed network communication chips [3] Group 2 - Youyou Foods plans to use 10 million yuan of its own funds to purchase principal-protected financial products with an expected annual yield of 0.5%-5.0% [4] - Yangfan New Materials announced the release of detention measures against its controlling shareholder, allowing him to resume his duties [5] - Xianju Pharmaceutical received approval for a supplementary application for Nicardipine injection, a calcium channel blocker used for acute hypertension [6] Group 3 - Jingu Co. plans to repurchase shares worth 30-60 million yuan for employee stock ownership plans or equity incentives [7] - Double Tower Foods' Thai subsidiary has completed the construction of its production line and is in the initial production phase [8] - Tongyi Zhong intends to invest approximately 198 million yuan in a project for the industrialization of ultra-high molecular weight polyethylene fibers [9][10] Group 4 - Zhangyue Technology received a dividend of 4.99 million yuan from its stake in Dianzhong Technology, which represents 10.12% of its audited net profit for 2024 [11] - Sihua Electronics announced the resignation of its general manager due to job transfer, with the current manager continuing until a new one is appointed [12] - Jiutian Pharmaceutical's new drug JMHT06 has received approval for clinical trials for acute gouty arthritis [13] Group 5 - Anlian Ruishi has established a joint venture for embodied intelligent robots with a registered capital of 20 million yuan [14] - Kelin Electric's application for a private placement has been accepted by the Shanghai Stock Exchange [15] - Guoyao Modern's subsidiary has received approval for the listing of Agomelatine raw materials, used in antidepressant synthesis [16] Group 6 - Xintiandi's application for the listing of Ferrous Fumarate raw materials has been approved, which is used for treating iron deficiency anemia [17] - ST Weihai, as the leading party, won a bid for a smart agriculture project worth 652 million yuan, accounting for 26.27% of its 2024 audited revenue [18] - Tian Youwei plans to purchase 100% of Krämer Automotive Systems for 1 million euros [19] Group 7 - Guangdong Yuedian A's subsidiary has successfully put into operation the third unit of its Dapu Power Plant project [20] - China Life's total premium exceeded 700 billion yuan as of November 30, 2025 [21] - Shoukai Co. achieved a total signed amount of 15.988 billion yuan in the first 11 months of 2025 [22] Group 8 - Kehua Bio's subsidiary has obtained a medical device registration certificate for an automatic chemiluminescence immunoassay analyzer [23] - Chengyi Pharmaceutical received a drug registration certificate for Torasemide tablets, which have passed the consistency evaluation [24] - Chongqing Construction won a bid for a municipal engineering project worth approximately 1.714 billion yuan [25] Group 9 - Hanjian Heshan signed a procurement contract for pipes worth 388 million yuan [26] - Jiuzhou Pharmaceutical plans to use up to 1 billion yuan of idle raised funds for cash management [27] - Xinwufeng reported an 80.97% year-on-year increase in pig sales in November 2025 [28] Group 10 - Luoniushan reported a 13.57% year-on-year increase in pig sales revenue in November 2025 [29] - Fushilai received a drug registration certificate for Alpha-Lipoic Acid tablets, used for diabetic neuropathy [30] - Dizhe Pharmaceutical presented research data on two innovative drugs at the 67th American Society of Hematology conference [31] - David Medical's subsidiary received two medical device registration certificates for single-use gastric tubes and electronic ureteral endoscope catheters [32]